Skip to content

Clinical trials

Phase 1 Esophageal Squamous Cell Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Phase: Phase 1 Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20051
20061
20071
20081
20111
20121
20132
20141
20163
20171
20181
20198
20208
20214
20223
20238
20247
202511
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting18
Terminated13
Unknown status7
Active, not recruiting6
Not yet recruiting4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Memorial Sloan Kettering Cancer Center3
Seagen, a wholly owned subsidiary of Pfizer3
Sun Yat-sen University3
Exelixis2
Hebei Medical University Fourth Hospital2
IDEAYA Biosciences2
Incyte Corporation2
Peking University2
Sichuan University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma72
Carcinoma, Non-Small-Cell Lung23
Squamous Cell Carcinoma of Head and Neck22
Esophageal Neoplasms16
Colorectal Neoplasms14
Stomach Neoplasms14
Triple Negative Breast Neoplasms13
Neoplasm Metastasis11
Uterine Cervical Neoplasms11
Carcinoma, Hepatocellular9

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.